Long-term benefit of enzyme replacement therapy with alglucosidase alfa in adults with Pompe disease: prospective analysis from the French Pompe Registry
Semplicini C, De Antonio M, Taouagh N, Béhin A, Bouhour F, Echaniz-Laguna A, Magot A, Nadaj-Pakleza A, Orlikowski D, Sacconi S, Salort-Campana E, Solé G, Tard C, Zagnoli F, Jean-Yves H, Hamroun D, Laforêt P; French Pompe Study Group
J Inherit Metab Dis. 2020. doi: 10.1002/jimd.12272.
This study reports the findings from 158 patients treated by Enzyme Replacement Therapy and included in a French Pompe Registry.
A two-phases model described the changes in MFM scores after treatment implementation. MFM total score showed an initial significant increase (6.6% ±2.3/year) followed by a -1.13%/year (change of slope: -7.7 ±2.3, p<0.01) decline after 0.5 years. D1and D2 sub-scores showed a progressive decline (-1.0%±0.1/year, p<0.001), while D3 score showed a slow progressive decline (-0.2%±0.1/year, p<0.05), confirming that the distal muscle functions impairment is minimal in Pompe Disease..
Keywords: Pompe disease, Sensitivity to change
Articles in scientific journals
Rasch analysis of clinical outcome measures in spinal muscular atrophy
SJ. Cano, A. Mayhew, AM. Glanzman, KJ. Krosschell, KJ. Swoboda, M. Main, BF. Steffensen, C. Bérard, F. Girardot, CA. Payan, E. Mercuri, E. Mazzone, B. Elsheikh, J. Florence, LS. Hynan, ST. Iannaccone , LL. Nelson, S. Pandya, M. Rose, C. Scott, R. Sadjadi, MA. Yore, C....
Gait energy expenditure in children with Duchenne muscular dystrophy: case study
de Souza MA, Ferreira ME, Rogean de Jesus Alves de Baptista C, Mattiello Sverzut AC. Fisioter Pesq. 2014. 21(2):193-198. Energy expenditure of 3 children (6, 7 and 8 years old) with MFM scores between 61.5 and 71.7% was calculated using gait heart rate (HR).Results...
Physiotherapy Intervention in Nemaline Myopathy – Case Report
Furlaneto B, Valenciano P, Zechim F, Alves E. Revista Neurociências. 2014. 22(1):59-65. This report provides an understanding of the clinical evolution and prognosis of a Nemaline Myopathy (NM) patient compared with the literature.Physiotherapeutic interventions were...
Activity rating scales in adult muscle disease: how well do they actually measure?
Seedat F, James MK, Rose MR. Muscle Nerve. 2014. 50(1):24-33. Systematic review to assess the quality of 19 activity rating scales, including the MFM, designed specifically for muscle disease.PubMed linkKeywords: Functional rating scales, Muscle disease, Outcome...
Activity rating scales in adult muscle disease: what do they actually measure?
Seedat F, James MK, Rose MR. Muscle Nerve. 2014. 50(1):14-23. Literature review of activity rating scales used for muscle disease and assessed their content by linking scale items to the International Classification of Functioning, Disability and Health (ICF) and the...
The Use of Functional Scales for Clinical Evaluation of Duchenne Muscular Dystrophy
Barra TMF, Baraldi KF Revista Neurociências. 2013. 21(3):420-426. Literature review of scientific articles, books and dissertations published from 2000 to 2011, in Portuguese, English and Spanish languages to demonstrate the applicability of using Vignos scales, Egen...